John Hunter Peel Alexander, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St, Durham, NC 27705
Phone (919) 668-8955
Email address john.h.alexander@duke.edu

John H. Alexander, MD, MHS is a cardiologist and Professor of Medicine in the Department of Medicine, Division of Cardiology at Duke University School of Medicine, as well as the Vice Chief, Clinical Research in the Division of Cardiology. He is the Director of Cardiovascular Research at the Duke Clinical Research Institute where he oversees a large group of clinical research faculty and a broad portfolio of cardiovascular clinical trials and observational clinical research programs. He is a member of the American Society of Clinical Investigation.

Dr. Alexander’s clinical interests are in acute and general cardiovascular disease, valvular heart disease, and echocardiology. His research is focused on the translation of novel therapeutic concepts into clinical data through clinical trials, specifically on the therapeutics of acute coronary syndromes, chronic coronary artery disease, and cardiac surgery and on novel methodological approaches to clinical trials. He was on the Executive Committee of the ARISTOTLE trial of apixaban in patients with atrial fibrillation and was the Principal Investigator of the APPRAISE-2 trial of apixaban in patients with acute coronary syndromes.

Dr. Alexander has published extensively and has served as the principal investigator of numerous multicenter clinical trials. He currently serves as the co-chair of the Clinical Trial Transformation Initiative (CTTI).

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1996 - 2000
  • Medical Resident, Medicine, Children's Hospital Boston, 1993 - 1996
  • M.D., University of Pennsylvania, 1993

Publications

MEND-CABG II Investigators, , Alexander, JH, Emery, RW, Carrier, M, Ellis, SJ, Mehta, RH, Hasselblad, V, Menasche, P, Khalil, A, Cote, R, Bennett-Guerrero, E, Mack, MJ, Schuler, G, Harrington, RA, and Tardif, J-C. "Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial." Jama 299, no. 15 (April 2008): 1777-1787.

PMID
18381567
Full Text

Mehta, RH, Alexander, JH, Emery, R, Ellis, SJ, Hasselblad, V, Khalil, A, Carrier, M, Harrington, RA, Tardif, J-C, and MEND-CABG II Investigators, . "A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale." Am Heart J 155, no. 4 (April 2008): 600-608.

PMID
18371465
Full Text

Magee, MJ, Alexander, JH, Hafley, G, Ferguson, TB, Gibson, CM, Harrington, RA, Peterson, ED, Califf, RM, Kouchoukos, NT, Herbert, MA, Mack, MJ, and PREVENT IV Investigators, . "Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV." The Annals of Thoracic Surgery 85, no. 2 (February 2008): 494-499.

PMID
18222251
Full Text

Olenchock, SA, Karmpaliotis, D, Gibson, WJ, Murphy, SA, Southard, MC, Ciaglo, L, Buros, J, Mack, MJ, Alexander, JH, Harrington, RA, Califf, RM, Kouchoukos, NT, Ferguson, TB, and Gibson, CM. "Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters." The Annals of Thoracic Surgery 85, no. 2 (February 2008): 520-524.

PMID
18222256
Full Text

Harrington, RA, Alexander, JH, Hochman, JS, Reynolds, HR, Dzavik, V, and Van De Werf, FJ. "Tilarginine in patients with acute myocardial infarction and cardiogenic shock - In reply [7]." Journal of the American Medical Association 298, no. 9 (September 5, 2007): 972-973. (Letter)

Full Text

Cohen, M, Bhatt, DL, Alexander, JH, Montalescot, G, Bode, C, Henry, T, Tamby, J-F, Saaiman, J, Simek, S, De Swart, J, and SEPIA-PCI Trial Investigators, . "Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial." Circulation 115, no. 20 (May 22, 2007): 2642-2651.

PMID
17502577
Full Text

Dzavík, V, Cotter, G, Reynolds, HR, Alexander, JH, Ramanathan, K, Stebbins, AL, Hathaway, D, Farkouh, ME, Ohman, EM, Baran, DA, Prondzinsky, R, Panza, JA, Cantor, WJ, Vered, Z, Buller, CE, Kleiman, NS, Webb, JG, Holmes, DR, Parrillo, JE, Hazen, SL, Gross, SS, Harrington, RA, Hochman, JS, and SHould we inhibit nitric Oxide synthase in Cardiogenic shocK 2 (SHOCK-2) investigators, . "Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study." Eur Heart J 28, no. 9 (May 2007): 1109-1116.

PMID
17459901
Full Text

TRIUMPH Investigators, , Alexander, JH, Reynolds, HR, Stebbins, AL, Dzavik, V, Harrington, RA, Van de Werf, F, and Hochman, JS. "Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial." Jama 297, no. 15 (April 2007): 1657-1666.

PMID
17387132
Full Text

Gheorghiade, M, Konstam, MA, Burnett, JC, Grinfeld, L, Maggioni, AP, Swedberg, K, Udelson, JE, Zannad, F, Cook, T, Ouyang, J, Zimmer, C, Orlandi, C, and Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators, . "Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials." Jama 297, no. 12 (March 25, 2007): 1332-1343.

PMID
17384438
Full Text

Goyal, A, Alexander, JH, Hafley, GE, Graham, SH, Mehta, RH, Mack, MJ, Wolf, RK, Cohn, LH, Kouchoukos, NT, Harrington, RA, Gennevois, D, Gibson, CM, Califf, RM, Ferguson, TB, Peterson, ED, and PREVENT IV Investigators, . "Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery." The Annals of Thoracic Surgery 83, no. 3 (March 2007): 993-1001.

PMID
17307447
Full Text

Pages